Avidity Partners Management LP
46 holdingsFiling period: 2026-03-31Current AUM: $563.6Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | DNTH | DIANTHUS THERAPEUTICS INC | 2.10M | $184.7M | $235.4M | 41.77% | -- | 2026-03-31 |
| 2 | ORKA | ORUKA THERAPEUTICS INC | 760.4K | $52.0M | $102.4M | 18.16% | +100.0K | 2026-03-31 |
| 3 | JBIO | JADE BIOSCIENCES INC | 1.40M | $34.2M | $48.0M | 8.52% | -- | 2026-03-31 |
| 4 | CATX | PERSPECTIVE THERAPEUTICS INC | 6.05M | $23.6M | $16.5M | 2.92% | +2.84M | 2026-03-31 |
| 5 | ELVN | ENLIVEN THERAPEUTICS INC | 400.0K | $16.5M | $23.1M | 4.09% | +259.7K | 2026-03-31 |
| 6 | CNTX | CONTEXT THERAPEUTICS INC | 5.00M | $11.8M | $2.7M | 0.48% | -506,588 | 2026-03-31 |
| 7 | RGEN | REPLIGEN CORP | 77.8K | $9.2M | $11.0M | 1.95% | +27.5K | 2026-03-31 |
| 8 | PVLA | PALVELLA THERAPEUTICS INC NE | 70.0K | $9.0M | $10.0M | 1.78% | +50.7K | 2026-03-31 |
| 9 | AKTS | AKTIS ONCOLOGY INC | 468.6K | $8.8M | $10.8M | 1.92% | -- | 2026-03-31 |
| 10 | — | MEDTRONIC PLC | 100.0K | $8.1M | $8.1M | 1.44% | -7,600 | 2026-03-31 |
| 11 | TEVA | TEVA PHARMACEUTICAL INDS LTD | 200.0K | $7.0M | $8.2M | 1.45% | -217,300 | 2026-03-31 |
| 12 | VTL | IMMUNIC INC | 669.9K | $6.4M | $6.4M | 1.14% | -4,029,470 | 2026-03-31 |
| 13 | VIR | VIR BIOTECHNOLOGY INC | 619.3K | $6.3M | $6.1M | 1.08% | -- | 2026-03-31 |
| 14 | DXCM | DEXCOM INC | 100.0K | $6.0M | $7.9M | 1.40% | -- | 2026-03-31 |
| 15 | HUM | HUMANA INC | 25.0K | $5.9M | $12.4M | 2.20% | -- | 2026-03-31 |
| 16 | EHC | ENCOMPASS HEALTH CORP | 42.0K | $4.2M | $4.8M | 0.86% | +10.4K | 2026-03-31 |
| 17 | KPTI | KARYOPHARM THERAPEUTICS INC | 463.7K | $3.9M | $1.3M | 0.24% | +329.2K | 2026-03-31 |
| 18 | TEM | TEMPUS AI INC | 65.0K | $3.6M | $3.5M | 0.62% | -- | 2026-03-31 |
| 19 | TENX | TENAX THERAPEUTICS INC | 265.9K | $3.5M | $3.0M | 0.53% | -- | 2026-03-31 |
| 20 | BSX | BOSTON SCIENTIFIC CORP | 60.0K | $3.5M | $2.6M | 0.46% | -54,500 | 2026-03-31 |
| 21 | MSLE | SATELLOS BIOSCIENCE INC | 387.8K | $3.1M | $5.5M | 0.97% | -- | 2026-03-31 |
| 22 | PHAT | PHATHOM PHARMACEUTICALS INC | 249.4K | $2.8M | $2.2M | 0.39% | +43.3K | 2026-03-31 |
| 23 | GILD | GILEAD SCIENCES INC | 20.0K | $2.6M | $2.4M | 0.43% | -- | 2026-03-31 |
| 24 | GPCR | STRUCTURE THERAPEUTICS INC | 48.0K | $2.0M | $2.0M | 0.35% | -- | 2026-03-31 |
| 25 | SCYX | SCYNEXIS INC | 2.08M | $1.9M | $1.3M | 0.23% | -- | 2026-03-31 |
← Scroll →
Page 1 of 2